Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (45) 45
life sciences & biomedicine (44) 44
humans (37) 37
female (25) 25
male (25) 25
octreotide - analogs & derivatives (23) 23
middle aged (21) 21
tumors (21) 21
oncology (20) 20
aged (19) 19
adult (18) 18
octreotide - therapeutic use (18) 18
radiology, nuclear medicine & medical imaging (18) 18
neuroendocrine tumors - radiotherapy (17) 17
endocrinology & metabolism (13) 13
organometallic compounds - therapeutic use (13) 13
aged, 80 and over (12) 12
radiopharmaceuticals - therapeutic use (12) 12
treatment outcome (12) 12
nuclear medicine (11) 11
peptides (11) 11
toxicity (11) 11
patients (10) 10
peptide receptor radionuclide therapy (10) 10
somatostatin (10) 10
metastases (9) 9
neuroendocrine tumors (9) 9
octreotide - adverse effects (9) 9
cancer (8) 8
medicine & public health (8) 8
metastasis (8) 8
organometallic compounds - adverse effects (8) 8
pancreatic neoplasms - radiotherapy (8) 8
prrt (8) 8
cardiology (7) 7
imaging / radiology (7) 7
neuroendocrine tumors - pathology (7) 7
orthopedics (7) 7
radiation therapy (7) 7
original (6) 6
original article (6) 6
pancreatic neoplasms - pathology (6) 6
prognosis (6) 6
quality of life (6) 6
retrospective studies (6) 6
stomach neoplasms - radiotherapy (6) 6
thyroid (6) 6
adolescent (5) 5
biological and medical sciences (5) 5
bone marrow (5) 5
dosimetry (5) 5
intestinal neoplasms - radiotherapy (5) 5
lutetium (5) 5
medical imaging (5) 5
medical sciences (5) 5
octreotide - administration & dosage (5) 5
radioisotopes - therapeutic use (5) 5
research (5) 5
surgery (5) 5
survival (5) 5
thyroid cancer (5) 5
animals (4) 4
care and treatment (4) 4
incidence (4) 4
leukemia (4) 4
lu-dotatate (4) 4
lu-octreotate (4) 4
medical treatment (4) 4
neuroendocrine tumors - drug therapy (4) 4
octreotate (4) 4
prospective studies (4) 4
radioisotopes (4) 4
radiology nuclear medicine and imaging (4) 4
radiopharmaceuticals (4) 4
radiopharmaceuticals - adverse effects (4) 4
receptors, peptide - metabolism (4) 4
risk factors (4) 4
somatostatin - analogs & derivatives (4) 4
therapy (4) 4
tyr (4) 4
young adult (4) 4
177lu-dotatate (3) 3
abridged index medicus (3) 3
analysis (3) 3
cancer therapies (3) 3
chemotherapy (3) 3
disease progression (3) 3
disease-free survival (3) 3
drug therapy (3) 3
endocrine system (3) 3
gastrointestinal neoplasms - radiotherapy (3) 3
gene expression (3) 3
hematology (3) 3
heterocyclic compounds (3) 3
hypothyroidism (3) 3
lu-dota (3) 3
medical prognosis (3) 3
myelodysplastic syndrome (3) 3
neoplasm metastasis (3) 3
neoplasms - radiotherapy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Long-term efficacy, survival, and safety of [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors
by Brabander, Tessa and Van Der Zwan, Wouter A and Teunissen, Jaap J.M and Kam, Boen L.R and Feelders, Richard A and De Herder, Wouter W and Van Eijck, Casper H.J and Franssen, Gaston J.H and Krenning, Eric P and Kwekkeboom, Dik J
Clinical cancer research, ISSN 1078-0432, 08/2017, Volume 23, Issue 16, pp. 4617 - 4624
Life Sciences & Biomedicine | Oncology | Science & Technology | Outcome Assessment (Health Care) - methods | Humans | Middle Aged | Male | Intestinal Neoplasms - radiotherapy | Leukemia - etiology | Time Factors | Aged, 80 and over | Organometallic Compounds - therapeutic use | Adult | Female | Stomach Neoplasms - radiotherapy | Acute Disease | Octreotide - analogs & derivatives | Organometallic Compounds - adverse effects | Kaplan-Meier Estimate | Octreotide - adverse effects | Pancreatic Neoplasms - radiotherapy | Treatment Outcome | Octreotide - therapeutic use | Myelodysplastic Syndromes - etiology | Neuroendocrine Tumors - radiotherapy | Bronchial Neoplasms - radiotherapy | Outcome Assessment (Health Care) - statistics & numerical data | Aged | Radiopharmaceuticals - adverse effects | Radiopharmaceuticals - therapeutic use | Therapy | Membranes | Effectiveness | Kidneys | Toxicity | Leukemia | Radioisotopes | Cell membranes | Survival | Patients | Lutetium | Myelodysplastic syndrome | Metastases | Confidence intervals | Receptors | Experimental design | Safety engineering | Renal failure | Somatostatin | Safety | Somatostatin receptors | Tumors | Cancer | Neuroendocrine tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy
by van Vliet, Esther I and Teunissen, Jaap J.M and Kam, Boen L.R and de Jong, Marion and Krenning, Eric P and Kwekkeboom, Dik J
Neuroendocrinology, ISSN 0028-3835, 02/2013, Volume 97, Issue 1, pp. 74 - 85
Radiotherapy via SSTR | Somatostatin analogs | Gastroenteropancreatic neuroendocrine tumors | Radiolabeled somatostatin analogs | Peptide receptor radionuclide therapy | Endocrinology & Metabolism | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Radioisotopes - therapeutic use | Humans | Carcinoma, Neuroendocrine - therapy | Gastrointestinal Neoplasms - therapy | Radiopharmaceuticals - therapeutic use | Pancreatic Neoplasms - therapy | Receptors, Peptide - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls
by Beukhof, Carolien and Brabander, T and van Nederveen, FH and Velthuysen, Loes and Rijke, Yolanda and Hofland, Leo and Franssen, G.J.H and Froberg, L.A.C and Kam, Boen and Visser, Wil Edward and Herder, Wouter and Peeters, Robin
BMC cancer, ISSN 1471-2407, 01/2019, Volume 19, Issue 1, pp. 325 - 325
Life Sciences & Biomedicine | Oncology | Science & Technology | Care and treatment | Thyroid cancer | Research | Somatostatin | Gene expression | Thyroid cancer, medullary | Receptors, somatostatin | Peptide receptor radionuclide therapy | Lutetium
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Peptide-receptor radionuclide therapy for endocrine tumors
by Kwekkeboom, Dik J and van Essen, Martijn and de Jong, Marion and Krenning, Eric P and Valkema, Roelf and Kam, Boen L. R
Nature reviews. Endocrinology, ISSN 1759-5029, 07/2009, Volume 5, Issue 7, pp. 382 - 393
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Neuroendocrine Tumors - radiotherapy | Somatostatin - analogs & derivatives | Radioisotopes - therapeutic use | Octreotide - analogs & derivatives | Receptors, Peptide - therapeutic use | Humans | Somatostatin - therapeutic use | Octreotide - therapeutic use | Radiopharmaceuticals - therapeutic use | Receptors, Peptide - metabolism | Endocrine gland cancer | Care and treatment | Diagnosis | Research | Somatostatin | Radiotherapy | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Evaluation of the 2015 ATA Guidelines in Patients with Distant Metastatic Differentiated Thyroid Cancer
by Velsen, Evert and M. Stegenga and Kemenade, Folkert and Kam, Boen L. R and Ginhoven, Tessa and Edward Visser, W and Peeters, Robin
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 08/2019, Volume 105, Issue 3, pp. e457 - e465
American Thyroid Association Guidelines | Recurrence | Differentiated Thyroid Cancer | Prognosis | Survival | Distant Metastases | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Thyroid cancer | Surgery | Mastectomy | Metastasis | Patients | Thyroid | Metastases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate
by Bergsma, Henik and Konijnenberg, Mark and Zwan, Wouter and Kam, Boen and Teunissen, Jaap and Kooij, Peter and Mauff, Katya and Krenning, Eric and Kwekkeboom, Dik
European journal of nuclear medicine and molecular imaging, ISSN 1619-7070, 09/2016, Volume 43, Issue 10, pp. 1802 - 1811
PRRT | Kidneys | Renal function | Toxicity | 177Lu-Octreotate | Dosimetry | Nephrotoxicity | Oncology | 177 Lu-Octreotate | Medicine & Public Health | Orthopedics | Nuclear Medicine | Imaging / Radiology | Cardiology | Lu-Octreotate | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr 3]octreotate
by Keizer, Bart and Aken, Maarten and Feelders, Richard and Herder, Wouter and Kam, Boen and Essen, Martijn and Krenning, Eric and Kwekkeboom, Dik
European journal of nuclear medicine and molecular imaging, ISSN 1619-7070, 04/2008, Volume 35, Issue 4, pp. 749 - 755
Lu-177-octreotate | Carcinoid crisis | Peptide receptor radionuclide therapy | Neuroendocrine tumors | Medicine & Public Health | Orthopedics | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Octreotide - analogs & derivatives | Organometallic Compounds - adverse effects | Humans | Middle Aged | Radioisotopes - adverse effects | Endocrine System Diseases - etiology | Octreotide - adverse effects | Pancreatic Neoplasms - radiotherapy | Neuroendocrine Tumors - radiotherapy | Neuroectodermal Tumors, Primitive - radiotherapy | Gastrointestinal Neoplasms - radiotherapy | Adolescent | Aged, 80 and over | Adult | Aged | Retrospective Studies | Lutetium - adverse effects | Nuclear medicine | Side effects | Endocrine system | Radiation therapy | Hormones | Clinical outcomes | Cancer | Pharmaceuticals | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
by Bergsma, Hendrik, MD, PhD and van Vliet, Esther I., MD, PhD and Teunissen, Jaap J.M., MD, PhD and Kam, Boen L.R., MD and de Herder, Wouter W., MD, PhD and Peeters, Robin P., MD, PhD and Krenning, Eric P., MD, PhD and Kwekkeboom, Dik J., MD, PhD
Baillière's best practice & research. Clinical gastroenterology, ISSN 1521-6918, 2013, Volume 26, Issue 6, pp. 867 - 881
Gastroenterology and Hepatology | PRRT | Neuroendocrine tumours | Somatostatin analogues | Yttrium | Lutetium | Peptide receptor radionuclide therapy | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Stomach Neoplasms - radiotherapy | Somatostatin - analogs & derivatives | Octreotide - analogs & derivatives | Neuroendocrine Tumors - metabolism | Humans | Intestinal Neoplasms - metabolism | Stomach Neoplasms - metabolism | Octreotide - therapeutic use | Intestinal Neoplasms - radiotherapy | Neuroendocrine Tumors - radiotherapy | Retreatment | Heterocyclic Compounds, 1-Ring - therapeutic use | Organometallic Compounds - therapeutic use | Peptides, Cyclic - therapeutic use | Receptors, Somatostatin - metabolism | Heterocyclic Compounds - therapeutic use | Somatostatin - metabolism | Yttrium Radioisotopes - therapeutic use | Radiopharmaceuticals - therapeutic use | Peptides | Heterocyclic compounds | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer
by van Velsen, Evert F.S and Stegenga, Merel T and van Kemenade, Folkert J and Kam, Boen L.R and van Ginhoven, Tessa M and Visser, W. Edward and Peeters, Robin P
Thyroid (New York, N.Y.), ISSN 1050-7256, 08/2018, Volume 28, Issue 8, pp. 976 - 981
Thyroid Cancer and Nodules | follicular thyroid cancer | TNM staging | prognosis | thyroid neoplasms | papillary thyroid cancer | survival | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text [111In-DTPA]octreotide Tumor Uptake in GEPNET Liver Metastases After Intra-Arterial Administration: An Overview of Preclinical and Clinical Observations and Implications for Tumor Radiation Dose After Peptide Radionuclide Therapy
by Pool, Stefan E and Kam, Boen L.R and Koning, Gerben A and Konijnenberg, Mark and ten Hagen, Timo L.M and Breeman, Woulter A.P and Krenning, Eric P and de Jong, Marion and van Eijck, Casper H.J
Cancer biotherapy & radiopharmaceuticals, ISSN 1084-9785, 05/2014, Volume 29, Issue 4, pp. 179 - 187
Original Articles | Radionuclide therapy | Liver metastases | Somatostatin | Intra-arterial injection | Neuroendocrine tumor | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Pharmacology & Pharmacy | Oncology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Liver Neoplasms, Experimental - secondary | Pancreatic Neoplasms - metabolism | Humans | Middle Aged | Rats, Inbred Lew | Stomach Neoplasms - metabolism | Male | Stomach Neoplasms - pathology | Octreotide - pharmacokinetics | Pentetic Acid - administration & dosage | Pentetic Acid - analogs & derivatives | Intestinal Neoplasms - radiotherapy | Pancreatic Neoplasms - drug therapy | Tissue Distribution | Liver Neoplasms, Experimental - metabolism | Liver Neoplasms, Experimental - radiotherapy | Adult | Female | Octreotide - administration & dosage | Disease Models, Animal | Neuroendocrine Tumors - pathology | Stomach Neoplasms - radiotherapy | Radiopharmaceuticals - pharmacokinetics | Octreotide - analogs & derivatives | Neuroendocrine Tumors - metabolism | Intestinal Neoplasms - metabolism | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - radiotherapy | Rats | Stomach Neoplasms - drug therapy | Pentetic Acid - pharmacokinetics | Intestinal Neoplasms - pathology | Radiopharmaceuticals - administration & dosage | Neuroendocrine Tumors - radiotherapy | Animals | Indium Radioisotopes - administration & dosage | Neuroendocrine Tumors - drug therapy | Intestinal Neoplasms - drug therapy | Infusions, Intra-Arterial | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients
by van Velsen, Evert F.S and Stegenga, Merel T and van Kemenade, Folkert J and Kam, Boen L.R and van Ginhoven, Tessa M and Visser, W. Edward and Peeters, Robin P
Thyroid (New York, N.Y.), ISSN 1050-7256, 08/2019, Volume 29, Issue 8, pp. 173 - 1079
Thyroid Cancer and Nodules | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights